Donald H. Horstman

Effectiveness of Fluticasone Propionate and Salmeterol Combination Delivered via the Diskus Device in the Treatment of Chronic Obstructive Pulmonary Disease

Donald A. Mahler, Patrick D. Wire, Donald H. Horstman et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 507 citations

Pulmonary Care, Allergy, Inflammatory Lung Disease +11

Ozone-induced Inflammation in the Lower Airways of Human Subjects

Hillel S. Koren, Robert B. Devlin, Delores E. Graham et al. · American Review of Respiratory Disease · 1989 · 496 citations

Asthma, Inflammatory Lung Disease, Lung Inflammation +18

The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD

Nicola A. Hanania, Patrick Darken, Donald H. Horstman et al. · CHEST Journal · 2003 · 327 citations

Pulmonary Care, Allergy, Advanced Lung Disease +7

Pulmonary effects of ozone exposure during exercise: dose-response characteristics

William F. McDonnell, Donald H. Horstman, Milan J. Hazucha et al. · Journal of Applied Physiology · 1983 · 313 citations

O3 Exposure, Air Quality, Ppm O3 +18

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD

David A. Lomas, Edward Silverman, Lisa Edwards et al. · European Respiratory Journal · 2009 · 234 citations · Full text

Asthma, Inflammation, Pulmonary Surfactant +13